About Buenos Aires Mácula
Clinical Trials at Buenos Aires Mácula
During the past decade, Buenos Aires Mácula conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Buenos Aires Mácula"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Buenos Aires Mácula
According to Clinical.Site data, the most researched conditions in "Buenos Aires Mácula" are
"Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Buenos Aires Mácula" in a lesser frequency.
Clinical Trials Intervention Types at Buenos Aires Mácula
Most popular intervention types in "Buenos Aires Mácula" are "Drug" (6 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (6 trials), "Faricimab" (4 trials), "Aflibercept" (3 trials), "RO7200220" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Buenos Aires Mácula
The vast majority of trials in "Buenos Aires Mácula" are
6 trials for "All" genders.
Clinical Trials Status at Buenos Aires Mácula
Currently, there are NaN active trials in "Buenos Aires Mácula".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Buenos Aires Mácula,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Buenos Aires Mácula, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".